Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,149 public trials 552 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine M72/AS01E in Participants With Well-controlled HIV

NCT04556981

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Wits RHI Johannesburg, Gauteng, South Africa

Ekhaya VAC Cape Town, Khayelitsha, South Africa

CAPRISA Durban, KwaZulu-Natal, South Africa

The Aurum Institute Klerksdorp, North West, South Africa

View Trial Details

Completed

Single-Dose Islatravir in Moderate Hepatic Impairment (MK-8591-030)

NCT04515641

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Clinical Pharmacology of Miami ( Site 0001) Miami, Florida, United States

View Trial Details

Completed

Rural Dementia Caregiver Project

NCT04428112

Conditions: AIDS Dementia Complex, Alzheimer Disease, Arterial Occlusive Diseases, +69 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

GSK3739937 First-Time-In-Human (FTIH) Study in Healthy Volunteers

NCT04493684

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: GSK Investigational Site Baltimore, Maryland, United States

View Trial Details

Completed

HIV And Parasitic Infection (HAPI) Study

NCT05323396

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations: Lighthouse Clinic Lilongwe, Malawi

View Trial Details

Completed

A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B

NCT04544956

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Investigational Site Boston, Massachusetts, United States

GSK Investigational Site Toronto, Ontario, Canada

GSK Investigational Site Rotterdam, Netherlands

GSK Investigational Site London, United Kingdom

View Trial Details

Completed

Improving Uptake and Adherence to HIV Prevention Services With Pre-exposure Prophylaxis (PrEP), HIV Self- Testing and Adherence Support for Very High Risk HIV-negative Young Women Aged 15-24 in Kampala, Uganda

NCT04030520

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Uganda Virus Research Institute Entebbe, Uganda

View Trial Details

Completed

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

NCT02940496

Conditions: Adenocarcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, +28 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Peg-interferon for Inactive Chronic Hepatitis B Carriers

NCT02992704

Conditions: Blood-Borne Infections, Carrier of Viral Hepatitis Type B, Chronic Disease, +16 more
Locations: National University Hospital Singapore

View Trial Details

Completed

Acupuncture Therapy VS Chiropractor Group Therapy to Reduce Anxiety and Depression.

NCT05936905

Conditions: Acquired Immunodeficiency Syndrome, Anxiety Depression, Anxiety Disorders, +20 more
Locations: Yo San University Los Angeles, California, United States

View Trial Details

Communicable Diseases

Communicable Diseases trial results

Related conditions